Cited by 50Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCholesterol and Lipid Metabolism

Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus

Open access
Akram, Afia, Schmeidler, James, Katsel, Pavel, Hof, Patrick R., Haroutunian, Vahram·2010·Brain Research

Abstract

To gain insight into ATP-binding cassette transporter A1 (ABCA1) function and its potential role in AD pathology, we analyzed the expression of the cholesterol transporter ABCA1 in postmortem hippocampus from persons at different stages of dementia and AD associated neuropathology relative to cognitively intact normal donors by quantitative polymerase chain reaction (qPCR) and Western blot. In this study clinical dementia rating (CDR) scores were used as a measure of dementia severity, whereas, Braak neuropathological staging and neuritic plaque density were used as an index of the neuropathological progression of AD. Correlation analysis showed that ABCA1 mRNA expression was significantly elevated at the earliest recognizable stage of dementia compared to persons with intact cognition. ABCA1 mRNA was also positively correlated with Braak neuropathological stages and neuritic plaque density counts. Additionally, ABCA1 mRNA levels showed robust correlation with dementia severity even after controlling for the confounding contribution of accompanying neuropathological parameters to ABCA1 mRNA expression. Western blot analyses showed that the differential expression observed at the transcriptional level is also reflected at the protein level. Thus, our study provides transcriptional and translational evidence that the expression of ABCA1, a key modulator of cholesterol transport across the plasma membrane, is dysregulated in the AD brain and that this dysregulation is associated with increasing severity of AD, whether measured functionally as dementia severity or neuropathologically as increased neuritic plaque and neurofibrillary tangle density.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2010.01.006

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Holtzman DM Fagan AM Mackey B Tenkova T Sartorius L Paul SM Bales K Ashe KH Irizarry MC Hyman BT Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model Ann Neurol 2000 47 739 747 10852539

Cited by

Sorted by citations

Authors
Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • James J. Peters VA Medical Center (US)
Corresponding author
Akram, Afia
Venue
Brain Research
Publisher
Elsevier BV
Published
2010-03
Volume
1318
Pages
167-177
ISSN
0006-8993 (ISSN-L)
OpenAlex
W1987562492
Cited by
50
References
96
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 2 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 6
FWCI
3.66
Type
journal article
Language
en
Open access
Locations
  • Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
NIH (P01 AG02219, AG05138)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
ABCA1, Alzheimer's disease, dementia severity, hippocampus, cholesterol transport, neuritic plaques, Braak staging, neurofibrillary tangles, gene expression, postmortem brain
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Male, Psychiatric Status Rating Scales, RNA, Messenger, Severity of Illness Index, Blotting, Western, Cohort Studies, Polymerase Chain Reaction, ATP-Binding Cassette Transporters, Plaque, Amyloid, ATP Binding Cassette Transporter 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review